Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp V.SVA


Primary Symbol: T.SVA Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Post by Sonny7on Dec 03, 2020 11:08am
558 Views
Post# 32026019

Last Nights News

Last Nights News

 

Sernova 12,218,333-share private placement

 

2020-12-02 21:34 MT - Private Placement - Debenture

 

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced Sept. 9, 2020.

 

Number of shares:  12,218,333 shares

Purchase price:  30 cents per share

Warrants:  12,218,333 share purchase warrants to purchase 12,218,333 shares

Warrant exercise price:  35 cents for a two-year period, subject to an acceleration clause

Number of placees:  53 placees

Insiders:  2578606 Ontario Inc. (Deborah Brown), 100,000; Frank Holler, 83,333; Jeffrey Bacha, 16,666; James Parsons, 10,000; Philip Toleikis, 45,002

Total pro group involvement:  48,000 (one placee)

Finders' fees:  Echelon Wealth Partners Inc., $3,675 cash and 12,250 finder's warrants payable; Gerhard Merkel, $15,959.98 cash and 53,200 finder's warrants payable; Hampton Securities Ltd., $20,643 cash and 68,810 finder's warrants payable; Public Eye Consulting Busche, $19,215 cash and 64,050 finder's warrants payable (Each finder's warrant is exercisable at 35 cents per common share until Sept. 22, 2022.)

<< Previous
Bullboard Posts
Next >>